Phase I trial of vorinostat combined with bortezomib for the treatment of relapsing and/or refractory multiple myeloma. - Weber DM; Graef T; Hussein M; Sobecks RM; Schiller GJ; Lupinacci L; Hardwick JS; Jagannath S (Clinical lymphoma, myeloma & leukemia, 2012)